Permanence Bio
We Protect the Genome
San Francisco, United States · Founded 2024 · $35.0M raised
- Headquarters
- San Francisco, California
- Employees
- 1–10
- Founded
- 2024
- Business Model
- B2B
- Website
- permanence.bio
- Total Funding
- $35.0M
- Last Round
- $20.0M Series AJan 2026
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Developing therapeutics to stop mutations to prevent cancer
Summary
Permanence Bio is a Biotech company based in San Francisco, United States, founded in 2024. It has raised $35.0M in total across 2 rounds, most recently a $20.0M Series A round in Jan 2026. Investors include Norwest Venture Partners, Permanent Capital and NFX.
Funding History
Jan 2026
Sign up to see all 2 events
Funding: Pre-Seed through Series A. Amounts, valuations, and investors where available.
Investors
Similar Companies
San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/permanence-bio"><img src="https://indexed.vc/api/badge/company/permanence-bio" alt="Permanence Bio on Indexed.vc" width="260" height="76" /></a>